Sulfamethoxypyridazine 500mg tablets
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
3 branded products available
WHO defined daily dose (DDD)
500 mg
Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.
Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via the NHS dm+d supplementary BNF/ATC mapping files (NHSBSA). Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 13 studies.
2019–2026
Showing all 13 studies, sorted by most relevant.
Muhammad Wajid, Muhammad Uzair, Gulzar Muhammad, et al.
ChemistrySelect, 2024
Liu WX, Zhou WN, Song S, et al.
2023
A new type of magnetic nanomaterial with Fe3O4 as the core and organic polymer as the shell was synthesized by seed emulsion polymerization. This material not only overcomes the problem of insufficient mechanical strength of the organic polymer, it also solves the problem that Fe3O4 is prone to oxidation and agglomeration. In order to make the particle size of Fe3O4 meet the requirement of the seed, the solvothermal method was used to prepare Fe3O4. The effects of the reaction time, amount of solvent, pH value, and polyethylene glycol (PEG) on the particle size of Fe3O4 were investigated. In addition, in order to accelerate the reaction rate, the feasibility of preparing Fe3O4 by microwave was studied. The results showed that under the optimum conditions, the particle size of Fe3O4 could reach 400 nm and had good magnetic properties. After three stages of oleic acid coating, seed emulsion polymerization, and C18 modification, the obtained C18-functionalized magnetic nanomaterials were used for the preparation of the chromatographic column. Under optimal conditions, stepwise elution significantly shortened the elution time of sulfamethyldiazine, sulfamethazine, sulfamethoxypyridazine, and sulfamethoxazole while still achieving a baseline separation.
Abstract licence: CC BY
Yang J, Yang Z, Wang J, et al.
2025
- Microplastics
- Anti-Bacterial Agents
- Sulfonamides
The prevalence of nanoplastics (NPs) and sulfonamide antibiotics (SAs) in the aquatic environment is potentially harmful to the environment, and these pollutants are often present in the environment in the form of composite ones, thereby introducing more complex effects and hazards to the environment. Therefore, it is crucial to investigate the toxic effects of the individual target pollutants and their mixtures. In this study, we used Scenedesmus obliquus as the test organisms, two types of NPs: polystyrene (PS) and amine-modified (NH 2 -PS), four SAs: sulfapyridine (SPY), sulfamethazine (SMR), sulfamethoxypyridazine (SMP), and sulfamethoxazole (SMZ), and their eight binary mixtures were examined. We investigated the toxic interactions of the eight binary mixtures on Scenedesmus obliquus and assessed the impact of the 14 mixtures on the physiological and biochemical properties of Scenedesmus obliquus . Interaction of pollutant assemblages with algal cells observed using field emission scanning electron microscopy. The results showed that the six target pollutants and their eight binary mixtures were significantly toxic to Scenedesmus obliquus within 96 h. The toxicity of individual pollutants was in the order of SPY (EC 50 : 12.38 mg/L) > SMZ (EC 50 : 20.43 mg/L) > SMP (EC 50 : 32.96 mg/L) > SMR (EC 50 : 41.06 mg/L) > PS (EC 50 : 284.13 mg/L) > NH 2 -PS (EC 50 : 754.13 mg/L); the toxicity of binary mixtures composed of NPs and SAs (89.13 ∼ 1905.46 mg/L) was generally less toxic than that of unitary SAs (12.38 ∼ 41.06 mg/L). Suggesting that the presence of NPs reduced the toxicity of the SAs. The different types of NPs influenced the interaction and toxicity of the mixtures. The effects-based model deviation ratio method was used to quantitatively assess the interactions of the mixture systems in the 10∼90 % experimental effect range. The majority of the PS-containing mixtures exhibited antagonistic interactions. The interactions of NH 2 -PS-containing mixtures on Scenedesmus obliquus showed different interactions depending on the concentration ratios of the mixture components. The exposure of two NPs and four SAs and their binary mixtures differently promoted or inhibited superoxide dismutase and catalase activities in algal cells to different degrees and resulted in elevated levels of malondialdehyde content, suggesting that oxidative stress led to significant inhibition of chlorophyll content, total protein content, and growth of algal cells. The SEM image can be a more intuitive means of observing the interaction of nanoplastics with algal cells. These findings offer valuable data for the ecological risk assessment of NPs and SAs. • Toxicity studies of nanoplastics and sulfonamide antibiotics on Scenedesmus obliquus . • Binary mixture of pollutants had antagonistic and synergistic effects. • Binary mixture of pollutants inhibits the growth of algal cells well. • Scanning electron microscopy reveals interactions between nanoplastics and algae.
Abstract licence: CC BY-NC
G. D. T. M. Jayasinghe, Joanna Szpunar, Ryszard Lobinski, et al.
Fishes, 2023
Antibiotics have been used to control the aquatic environment in both therapeutic and prophylactic ways. Antibiotics are particularly difficult to extract due to their strong interactions with biological matrices. In this study, UPLC-MS/MS method was developed and validated for quantitative confirmatory analysis of multi-class antibiotics residues in fish and shrimp. Fourteen antibiotics belonging to sulphonamides, β-lactams, quinolones, sulfones and macrolides were determined within one chromatographic run. The samples were suspended in 0.1 M HCl, and the analytes were extracted into ethyl acetate. The extracts were defatted with cyclohexane. The limits of quantification (LOQ) ranged from 0.24 to 1.32 µg kg−1 for fish and 0.42–1.62 µg kg−1 for shrimp samples. The recoveries ranged from 75 to 105%. The method was applied to the analysis of farmed freshwater Tilapia fish (Oreochromis niloticus) and shrimp (Penaeus monodon) collected in Sri Lanka. Sulfacetamide (4.31 ± 0.70 µg kg−1) and sulfamethoxypyridazine (0.75 ± 0.15 µg kg−1) were detected in the fish, and sulfapyridine (0.21–0.56 µg kg−1) and sulfadoxine (0.35–1.44 µg kg−1) were detected in the shrimp samples. The concentrations complied with the EU regulation limits for veterinary drug residues in seafood and did not pose a risk in terms of food safety.
Abstract licence: CC BY
Meiling Ping, Wenchao Lv, Chen Yang, et al.
Chemosensors, 2023
It is crucial that simple and high-throughput methods for determining multiple, or groups of, sulfonamides (SAs) be developed since they are widely used in animal husbandry and aquaculture. We developed a paper-based multicolor colorimetric aptasensor to detect 3 SAs: sulfaquinoxaline (SQ), sulfamethoxypyridazine (SMP) and sulfamethoxydiazine (SMD). Using a broad-specificity aptamer as a bioreceptor, we reduced the growth of nicotinamide adenine dinucleotide I (NADH)–ascorbic acid (AA)-mediated gold nanobipyramids (AuNBPs) to generate a multicolor signal. We also used a paper-based analytical device (PAD) system to deposit AuNBPs for a sensitive color signal read out. The aptasensor can detect more color changes corresponding to the concentrations of SQ, SMP and SMD and has higher sensitivity, better specificity and stability. It can also be used to determine SQ, SMP and SDM individually, or collectively, or any two together with a visual detection limit of 0.3–1.0 µM, a spectrometry quantification limit (LOQ) of 0.3–0.5 µM and a spectrometry detection limits (LOD) of 0.09–0.15 µM. The aptasensor was successfully used to determine SQ, SMP and SDM in fish muscle with a recovery of 89–94% and a RSD n = 5) < 8%, making it a promising method for the rapid screening of total SQ, SMP and SDM residue in seafood.
Abstract licence: CC BY
Clémence Verguin, Julie Brunet, Hubert Ferté, et al.
BMC Veterinary Research, 2026
Only 14 crowned sifaka (Propithecus coronatus), a critically endangered lemur species, are currently held in zoological institutions. Hydatigera kamiyai is a newly described cryptic species within the Hydatigera taeniaeformis complex. A 3-year-old crowned sifaka presented with acute right hemiparesis. Magnetic resonance imaging exam revealed a two-centimetre diameter left thalamic mass with severe oedema, suggestive of an abscess. Intravenous antimicrobial therapy was initiated with metronidazole and trimethoprim-sulfamethoxypyridazine and continued for one month, as blood culture results were inconclusive. Clinical follow-up included unremarkable complete blood work and repeated MRI exams. The latter revealed an 80% reduction in the size of the mass, associated with full clinical recovery within 60 days. Because some tapeworms, such as Taenia martis, can cause nodular lesions in various locations in humans and non-human primates, a deworming treatment was implemented. Simultaneous immunological testing for hydatidosis and cysticercosis was strongly positive (ELISA, serum immunoglobulin G: 1.741). Oral praziquantel at 25 mg/kg led to severe lethargy after a single dose. Abdominal ultrasound under volatile general anaesthesia revealed two three-centimetre diameter heterogeneous hepatic cavitary structures containing linear hyperechoic elements, with a 0.8-centimetre-thick wall. Oral deworming treatment was readjusted and consisted in 15 days of praziquantel, followed by one-month of albendazole. Four months following the appearance of the first clinical signs, the animal suddenly became comatose and died despite intensive care. Post-mortem exam revealed multiple 12-centimetre-long pseudosegmented larvae (strobilocerci) within hepatic lesions. Brain histology revealed a resolving chronic abscess inconsistent with a parasitic aetiology. The larvae isolated in the liver were identified as Hydatigera kamiyai through morphological and molecular approaches. This cryptic species, belonging to the Hydatigera genus, most likely uses rodents as intermediate hosts and domestic cats as definitive hosts to complete its life cycle. Based on a thorough literature review, this report is the first description of an infection by this cestode in a non-human primate. Non-human primates may serve as aberrant intermediate hosts for Hydatigera kamiyai, which raises concerns regarding its potential zoonotic risk. This case also underscores the importance of parasitological surveillance in zoological institutions and the relevance of One Health considerations.
Abstract licence: CC BY-NC-ND
Yuhang Lin, Anting Ding, Zhikang Deng, et al.
Antibiotics, 2026
Background: Traditional methods exhibit an extremely low removal efficiency for antibiotics in water, making an efficient and energy-saving approach urgently needed. Methods and Results: In this study, a novel catalytic approach based on the in situ generation of high-valent iron (Fe(IV)/Fe(V)) has been developed by adding biochar instead of modifying the electrode materials (in previous studies) for the efficient removal of sulfamethoxazole (SMX) from water. Fe(IV)/Fe(V) was produced by the anodic oxidation of low concentrations of Fe(III) and subsequently activated by nitrogen-doped corn stalk biochar (NBC). The results showed that the degradation efficiency increased from 50.83% to 90.67% within 60 min after the addition of nitrogen-modified biochar. The abundant defect structures, graphitic N and oxygen-containing functional groups in NBC endowed the catalyst with excellent activation capability. Quenching experiments and methyl phenyl sulfoxide (PMSO) probe experiments revealed that singlet oxygen (1O2) and Fe(IV)/Fe(V) were the main contributors to SMX degradation. Degradation pathways were inferred based on transformation products (TPs) and density functional theory (DFT) calculations. Ecotoxicity prediction using the ECOSAR program indicated that the TPs formed in the E/Fe(III)/NBC system exhibited markedly lower toxicity to aquatic organisms than the parent SMX. Furthermore, the E/Fe(III)/NBC system maintained a high degradation efficiency for SMX in real aquatic environments. Additionally, the E/Fe(III)/NBC system showed high removal rates for other sulfonamides such as sulfadiazine (SDZ), sulfamethoxypyridazine (SMP), sulfathiazole (STZ) and sulfadoxine (SDX). Conclusions: Overall, the E/Fe(III)/NBC system was demonstrated to be a highly efficient and sustainable technology for removing various antibiotics from water.
Abstract licence: CC BY
Mesci S, Kocaman B, Erturk AG, et al.
2026
- Antineoplastic Agents
- Antioxidants
- Colonic Neoplasms
ABSTRACT Comprehending the intricate mechanisms of apoptosis and its interaction with cytotoxic, antioxidant, and HDAC activities is imperative for devising effective cancer therapies. Sulfonamides and Schiff bases are compounds of pharmacological importance with known anticancer activity. Our study aimed to investigate the cytotoxic, antioxidant, HDAC, and apoptotic activities of new sulfonamide‐Schiff bases in human colon cancer cells (DLD‐1 and HT‐29). New sulfonamide‐derived Schiff base compounds ( 3a – d ) were synthesized from the condensation of sulfamethoxypyridazine ( 1 ) and various aromatic aldehydes, and were characterized by FTIR, NMR ( 1 H and 13 C/APT), UV‐Vis., and mass spectroscopy. Sulfonamide‐derived Schiff bases 3a–d and compound 1 exhibited significant anticancer activity against colorectal cancer cell lines (DLD‐1, HT‐29). In the MTT assay, 3c was most active in DLD‐1 (viability: 37.7%, IC₅₀ = 3.94 µM) and 3b in HT‐29 (viability: 46.6%, IC₅₀ = 3.26 µM). In the WST‐8 assay, 3c was strongest in DLD‐1 (viability: 45.9%, IC₅₀ = 17.95 µM). None of the compounds showed toxicity in normal colon cells (CCD‐18Co). qRT‐PCR revealed upregulation of apoptotic (BAX, p53, Caspase‐3/8/9) and antioxidant (SOD‐1/2, CAT, GSS) genes, notably by 3a in DLD‐1 and 3d in HT‐29, while 3c reduced BCL‐2 in HT‐29 cells. ELISA confirmed strong antioxidant induction ( 3a : 70% in DLD‐1) and HDAC inhibition ( 3d : 69% in HT‐29). Western blot showed 3a increased p38/MAPK expression sevenfold in DLD‐1 and fourfold in HT‐29, while decreasing ERK1. Overall, 3c and 3d emerged as the most promising candidates, combining cytotoxic, antioxidant, HDAC inhibitory, and apoptotic effects, and may act as selective therapeutic agents by targeting the p38/MAPK–ERK1 pathway in colorectal cancer.
Abstract licence: CC BY
Yu-qiong Gao, N. Gao, W. Chu, et al.
Chemical Engineering Journal, 2019
Xiaolan Zeng, Xueli Wang, Shuang Shu, et al.
Materials Science in Semiconductor Processing, 2025
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Investigational
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 169 interactions
ATC J01ED05
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Sulfamethoxypyridazine
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q7636177), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. WHO INN from the World Health Organization.